About Protara Therapeutics, Inc.
Protara Therapeutics is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Founded on the principle of applying modern scientific, regulatory, and manufacturing advancements to established mechanisms, the company creates accelerated development opportunities that can bring life-changing treatments to patients faster. Protara's lead investigational therapy, TARA-002, is a cell therapy based on the broad immunopotentiator OK-432, which is already approved in Japan and Taiwan for multiple oncologic indications and lymphatic malformations. The company is evaluating TARA-002 for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs) in the United States, having received Rare Pediatric Disease Designation from the FDA.
In addition to TARA-002, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement therapy designed for patients on parenteral support. Approximately 80% of these patients are choline deficient and have some degree of liver damage, representing a significant unmet medical need. IV Choline Chloride has the potential to become the first FDA-approved IV choline formulation for these patients. The Protara team values creativity, diverse perspectives, and tenacity in their pursuit of novel therapies, operating from their modern office in New York City's Flatiron District with a culture grounded in inclusivity, integrity, and collaboration.
FAQs
- Who is the CEO of Protara Therapeutics, Inc.?
- Jesse Shefferman is the CEO.
- What industries or markets does Protara Therapeutics, Inc. operate in?
- Protara Therapeutics, Inc. operates in the following markets: Biotechnology, Oncology Therapeutics, Clinical Stage Biopharmaceuticals, Cancer Immunotherapy (Immuno Oncology), Urology Bladder Cancer (NMIBC) Treatments, Pediatric Rare Disease Drug Development, Parenteral Nutrition & IV Therapies, Liver Disease Hepatology Therapeutics, Cell Therapy, and Rare Disease Therapeutics.
- How many employees does Protara Therapeutics, Inc. have?
- Protara Therapeutics, Inc. has 11-50 employees.
- Where does Protara Therapeutics, Inc. have employees?
- Protara Therapeutics, Inc. has employees in United States.
- Is Protara Therapeutics, Inc. hiring?
- Yes, Protara Therapeutics, Inc. has 2 open remote jobs.
- Does Protara Therapeutics, Inc. support remote work or working from home?
- Yes, Protara Therapeutics, Inc. is a remote-friendly company.
- What employee benefits does Protara Therapeutics, Inc. offer?
- Protara Therapeutics, Inc. provides 12 benefits to their employees.
- Does Protara Therapeutics, Inc. offer a four-day work week?
- No, Protara Therapeutics, Inc. does not offer a four-day work week.
- Is Protara Therapeutics, Inc. transparent about salaries?
- Yes, Protara Therapeutics, Inc. practices salary transparency, often including salary or compensation ranges in their job posts. They provide salary data for 2 roles.
- What is Protara Therapeutics, Inc.'s website?
- Protara Therapeutics, Inc.'s website is protaratx.com.
United States